These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 18799100)

  • 1. Decreased CD20 expression in rheumatoid arthritis synovium following 8 weeks of rituximab therapy.
    Walsh CA; Fearon U; FitzGerald O; Veale DJ; Bresnihan B
    Clin Exp Rheumatol; 2008; 26(4):656-8. PubMed ID: 18799100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical analysis as a means to predict responsiveness to rituximab treatment.
    Teng YK; Levarht EW; Hashemi M; Bajema IM; Toes RE; Huizinga TW; van Laar JM
    Arthritis Rheum; 2007 Dec; 56(12):3909-18. PubMed ID: 18050222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of rituximab's immunomodulatory synovial effects (ARISE trial). 1: clinical and synovial biomarker results.
    Kavanaugh A; Rosengren S; Lee SJ; Hammaker D; Firestein GS; Kalunian K; Wei N; Boyle DL
    Ann Rheum Dis; 2008 Mar; 67(3):402-8. PubMed ID: 17644541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residual inflammation after rituximab treatment is associated with sustained synovial plasma cell infiltration and enhanced B cell repopulation.
    Teng YK; Levarht EW; Toes RE; Huizinga TW; van Laar JM
    Ann Rheum Dis; 2009 Jun; 68(6):1011-6. PubMed ID: 18647852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early effects of rituximab on the synovial cell infiltrate in patients with rheumatoid arthritis.
    Vos K; Thurlings RM; Wijbrandts CA; van Schaardenburg D; Gerlag DM; Tak PP
    Arthritis Rheum; 2007 Mar; 56(3):772-8. PubMed ID: 17328049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD20 antigen imaging with ¹²⁴I-rituximab PET/CT in patients with rheumatoid arthritis.
    Tran L; Huitema AD; van Rijswijk MH; Dinant HJ; Baars JW; Beijnen JH; Vogel WV
    Hum Antibodies; 2011; 20(1-2):29-35. PubMed ID: 21558621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synovial tissue response to rituximab: mechanism of action and identification of biomarkers of response.
    Thurlings RM; Vos K; Wijbrandts CA; Zwinderman AH; Gerlag DM; Tak PP
    Ann Rheum Dis; 2008 Jul; 67(7):917-25. PubMed ID: 17965121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [B cell targeting therapy using the anti-CD20 antibody in autoimmune diseases].
    Tanaka Y
    Yakugaku Zasshi; 2009 Jun; 129(6):675-9. PubMed ID: 19483410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of rituximab in the treatment of B cell malignancies: implications for rheumatoid arthritis.
    Hainsworth JD
    Arthritis Res Ther; 2003; 5 Suppl 4(Suppl 4):S12-6. PubMed ID: 15180892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-CD20 therapy in patients with rheumatoid arthritis: predictors of response and B cell subset regeneration after repeated treatment.
    Roll P; Dörner T; Tony HP
    Arthritis Rheum; 2008 Jun; 58(6):1566-75. PubMed ID: 18512772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of inflammatory immunologic disease 4. B cell targeting therapy using the anti-CD20 antibody rituximab in inflammatory autoimmune diseases.
    Tanaka Y
    Intern Med; 2007; 46(16):1313-5. PubMed ID: 17704614
    [No Abstract]   [Full Text] [Related]  

  • 12. B lymphocyte depletion in rheumatoid arthritis: targeting of CD20.
    Edwards JC; Leandro MJ; Cambridge G
    Curr Dir Autoimmun; 2005; 8():175-92. PubMed ID: 15564721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of refractory rheumatoid arthritis after depletion of B cells.
    Kneitz C; Wilhelm M; Tony HP
    Scand J Rheumatol; 2004; 33(2):82-6. PubMed ID: 15163108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical response, pharmacokinetics, development of human anti-chimaeric antibodies, and synovial tissue response to rituximab treatment in patients with rheumatoid arthritis.
    Thurlings RM; Teng O; Vos K; Gerlag DM; Aarden L; Stapel SO; van Laar JM; Tak PP; Wolbink GJ
    Ann Rheum Dis; 2010 Feb; 69(2):409-12. PubMed ID: 19596693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short- and long-term effects of anti-CD20 treatment on B cell ontogeny in bone marrow of patients with rheumatoid arthritis.
    Rehnberg M; Amu S; Tarkowski A; Bokarewa MI; Brisslert M
    Arthritis Res Ther; 2009; 11(4):R123. PubMed ID: 19686595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synovial infiltration with CD79a-positive B cells, but not other B cell lineage markers, correlates with joint destruction in rheumatoid arthritis.
    Mo YQ; Dai L; Zheng DH; Zhu LJ; Wei XN; Pessler F; Shen J; Zhang BY
    J Rheumatol; 2011 Nov; 38(11):2301-8. PubMed ID: 22002013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial.
    Bingham CO; Looney RJ; Deodhar A; Halsey N; Greenwald M; Codding C; Trzaskoma B; Martin F; Agarwal S; Kelman A
    Arthritis Rheum; 2010 Jan; 62(1):64-74. PubMed ID: 20039397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synovial expression of IL-15 in rheumatoid arthritis is not influenced by blockade of tumour necrosis factor.
    Ernestam S; af Klint E; Catrina AI; Sundberg E; Engström M; Klareskog L; Ulfgren AK
    Arthritis Res Ther; 2006; 8(1):R18. PubMed ID: 16507118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synovium CD20 expression is a potential new predictor of bone erosion progression in very-early arthritis treated by sequential DMARDs monotherapy -- a pilot study from the VErA cohort.
    Lanfant-Weybel K; Michot C; Daveau R; Milliez PY; Auquit-Auckbur I; Fardellone P; Brazier M; Mejjad O; Daragon A; Krzanowska K; Jouen F; Tron F; Le Loarer F; Le Loët X; Vittecoq O
    Joint Bone Spine; 2012 Dec; 79(6):574-80. PubMed ID: 22459417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New immunomodulators in the treatment of Graves' ophthalmopathy.
    Salvi M; Vannucchi G; Campi I; Currò N; Beck-Peccoz P
    Ann Endocrinol (Paris); 2008 Apr; 69(2):153-6. PubMed ID: 18417090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.